MGAT5, responsible for adding β1,6-GlcNAc branches to N-glycans, can promote immune evasion and oncogenic signaling in multiple solid tumors, including pancreatic, ovarian, and breast cancers (55, 56, 57, 58). This evidence concerns the gene MGAT5 and breast carcinoma.